QTRX
Quanterix Corp
Key Financials
Operating Income
$-125542000
↓ 138.6%
Revenue
$138.9M
↑ 1.1%
Net Income
$-107150000
↓ 178.1%
Gross Profit
$65.0M
↓ 21.8%
EPS (Diluted)
$-2.51
↓ 151.0%
Total Assets
$418.8M
↑ 3.0%
Total Liabilities
$123.0M
↑ 60.8%
Cash & Equivalents
$29.8M
↓ 47.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| SCHEDULE 13G | 8/6/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 4 | 7/16/2026 | View on SEC |
| 4 | 7/16/2026 | View on SEC |
| 4 | 7/9/2026 | View on SEC |
| 4 | 7/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | QTRX |
| Company Name | Quanterix Corp |
| CIK | 1503274 |
| Sector | Laboratory Analytical Instruments |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-301-9400 |